Erratum: Pagonabarraga, J.; et al. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. Brain Sci. 2020, 10, 176

Pagonabarraga, J. (Javier); Arbelo-González, J.M. (José Matías); Grandas, F. (Francisco); Luquin, M.R. (María Rosario); Martinez-Martin, P. (Pablo); Rodriguez-Oroz, M.C. (María Cruz); Valldeoriola, F. (Francesc); Kulisevsky, J. (Jaime)

Autor(es):

Pagonabarraga, J. (Javier)

Arbelo-González, J.M. (José Matías)

Grandas, F. (Francisco)

Luquin, M.R. (María Rosario)

Martinez-Martin, P. (Pablo)

Rodriguez-Oroz, M.C. (María Cruz)

Valldeoriola, F. (Francesc)

Kulisevsky, J. (Jaime)

Palabras clave :

Erratum
Abstract

Fecha de publicación :

2020

Editorial :

MDPI AG

ISSN :

2076-3425

Nota:

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Cita:

Pagonabarraga, J. (Javier); Arbelo-González, J.M. (José Matías); Grandas, F. (Francisco); et al. "Erratum: Pagonabarraga, J.; et al. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. Brain Sci. 2020, 10, 176". Brain sciences. 10 (5), 2020, 313

Resumen

We would like to submit the following erratum to our recently published paper [1] due to the errors in the abstract. We request (1) the removal of the word “motor” from the first line of the abstract, so that the sentence reads: “Safinamide is an approved drug for the treatment of fluctuations in Parkinson’s disease (PD)”, and (2) that the word “OFF” is changed to “ON” in line 6 of the abstract, so that the sentence reads: “Safinamide significantly improves the mean daily ON time without troublesome dyskinesias.”

URI :

https://hdl.handle.net/10171/68039

DOI:

10.3390/brainsci10050313

Aparece en las colecciones:

DA - CUN - Neurología - Artículos de revista

Ficheros en este ítem: